2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Jodie Ingles et al.|European Heart Journal|2023Cited by 2.3k
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)Gabrielle Norrish, Juan Pablo Kaski, Tao Ding et al.|JAMA Cardiology|2019Cited by 248
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad U. Rauf, Julian D. Gillmore, Philip N. Hawkins et al.|European Heart Journal|2023Cited by 95
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the <scp>AC‐TIVE</scp> study, an <scp>Italian nationwide survey</scp>Marco Merlo, Gianfranco Sinagra, Linda Pagura et al.|European Journal of Heart Failure|2022Cited by 91
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization — the first insight from the AC-TIVE StudyMarco Merlo, Gianfranco Sinagra, Aldostefano Porcari et al.|European Journal of Preventive Cardiology|2021Cited by 46